VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 119 filers reported holding VIR BIOTECHNOLOGY INC in Q3 2020. The put-call ratio across all filers is 0.98 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,454,792 | -59.6% | 261,987 | +5.8% | 0.00% | -57.1% |
| Q2 2023 | $6,073,946 | +110799.1% | 247,613 | +5.2% | 0.01% | 0.0% |
| Q1 2023 | $5,477 | -2.0% | 235,388 | +6.6% | 0.01% | -12.5% |
| Q4 2022 | $5,586 | -99.9% | 220,722 | -0.7% | 0.01% | +33.3% |
| Q3 2022 | $4,287,000 | -21.6% | 222,367 | +3.5% | 0.01% | -25.0% |
| Q2 2022 | $5,471,000 | +228.4% | 214,806 | +231.6% | 0.01% | +300.0% |
| Q1 2022 | $1,666,000 | -37.7% | 64,769 | +1.4% | 0.00% | -33.3% |
| Q4 2021 | $2,674,000 | -4.5% | 63,854 | -0.7% | 0.00% | -25.0% |
| Q3 2021 | $2,800,000 | -5.9% | 64,334 | +2.2% | 0.00% | 0.0% |
| Q2 2021 | $2,976,000 | -3.9% | 62,951 | +4.2% | 0.00% | 0.0% |
| Q1 2021 | $3,096,000 | +76.7% | 60,385 | -7.7% | 0.00% | +100.0% |
| Q4 2020 | $1,752,000 | -16.5% | 65,435 | +7.0% | 0.00% | -33.3% |
| Q3 2020 | $2,099,000 | -25.5% | 61,128 | -11.2% | 0.00% | -40.0% |
| Q2 2020 | $2,819,000 | +678.7% | 68,807 | +552.0% | 0.01% | +400.0% |
| Q1 2020 | $362,000 | – | 10,554 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,559,142 | $36,281,234 | 32.04% |
| SB INVESTMENT ADVISERS (UK) LTD | 18,319,938 | $426,304,957 | 3.50% |
| Zebra Capital Management LLC | 27,110 | $631 | 3.15% |
| Avidity Partners Management LP | 1,640,200 | $38,167,454 | 1.27% |
| Sofinnova Investments, Inc. | 657,559 | $15,301,398 | 0.98% |
| DCF Advisers, LLC | 62,000 | $1,442,740 | 0.88% |
| SECTOR GAMMA AS | 145,545 | $3,386,832 | 0.82% |
| Temasek Holdings (Private) Ltd | 5,814,972 | $135,314,398 | 0.80% |
| BRAIDWELL LP | 604,036 | $14,055,918 | 0.46% |
| SummerHaven Investment Management, LLC | 26,045 | $606,067 | 0.35% |